Zobrazeno 1 - 5
of 5
pro vyhledávání: '"tirozin kinaz inhibitörleri"'
Publikováno v:
Volume: 11, Issue: 4 202-223
Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi
Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi
OBJECTIVE: To assess the mutation status of the patients with Chronic Myeloid Leukemia (CML) who have been treated and followed-up in our clinics and to assess the response to the treatments.METHODS: All the patients with the diagnosis of CML (n:100)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::5dfaad22fc6ab5a2331897fcd9167d95
https://dergipark.org.tr/tr/pub/gutfd/issue/55410/759758
https://dergipark.org.tr/tr/pub/gutfd/issue/55410/759758
Autor:
Kamer, Tecen
The use of tyrosine kinase inhibitors as targeted therapies in cancer treatment becomes prevalent. The aim of this study was to determine and prevent drug-drug interactions and also to reduce side effects of thyrosine kinase inhibitors in patients by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4268::d9c07152d4dfa92e560e038745859dec
http://hdl.handle.net/11655/2925
http://hdl.handle.net/11655/2925
Autor:
Nursal, Ayşe Feyda
research Akciğer kanseri tüm dünyada kansere bağlı ölüm sebepleri içinde ilk sırada yer alır. Tedavi alanında tüm gelişmelere rağmen hala kötü prognoza sahiptir. Akciğer kanseri histolojik tipine göre küçük hücreli akciğer kans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1d66b26c95b20bcdf9f09230e4935c71
https://hdl.handle.net/11491/2646
https://hdl.handle.net/11491/2646
Autor:
NURSAL, Ayşe
Publikováno v:
Volume: 42, Issue: 1 117-122
Dicle Tıp Dergisi
Dicle Tıp Dergisi
Lung cancer is the most common reason of cancer mortality all over the world. Although smoking is the most important factor in lung cancer etiology, additionally, environmental, genetic and occupational factors also contribute to this disease. Despit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::8a91238ddf939e28e5e3a51fbea6c452
https://dergipark.org.tr/tr/pub/dicletip/issue/4712/64526
https://dergipark.org.tr/tr/pub/dicletip/issue/4712/64526
Publikováno v:
Volume: 31, Issue: 3 193-214
Journal of Faculty of Pharmacy of Ankara University
Journal of Faculty of Pharmacy of Ankara University
Günümüzde, mevcut ilaçlar ve kombinasyonları ile kanser kemoterapisi yetersiz kalmakta ve birçok kanser türünde tedavi sağlanamamaktadır. Angiogenesis, kanseri önleyici ilaç geliştirme araştırmaları için heyecan ve ümit verici bir a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::16beca52e26a46694b7d5745132df029
https://dergipark.org.tr/tr/pub/jfpanu/issue/35526/394434
https://dergipark.org.tr/tr/pub/jfpanu/issue/35526/394434